Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
THE BIG STORY: THE GREAT VACCINE RACE
|
Let out a cheer: the Department of Health made the amazing announcement today that it has sourced vaccines for our health workers!
We’re still awaiting the details, but this is great news given growing concern about SA’s vaccine plan. However, this issue is not straight-forward.
You may have read that SA’s authorities haven’t done well in securing vaccines for the country. This may be true, but not because of ineptitude. In the unprecedented race to develop a vaccine, there are hundreds on offer to countries, with little guarantee if they will work amid largely secrecy-clad negotiations by big pharma. Richer countries can afford to buy up many multiples for their populations, and bet against one of them working out. We just don’t have the financial muscle to do that. Even various new deals that see rich countries helping poorer ones, like the Covax facility you may have heard about, are a big gamble. (Within Covax, SA won’t get financial help as we are considered a middle-income country.)
Meanwhile, big pharma has come under pressure; activists are demanding that they make details of taxpayer-funded deals public. Billions in government and philanthropic funding have gone to these companies, and while they have committed to not making a profit off vaccines during the pandemic, they’re at liberty to decide when that commitment ends.
The irony is, at least four Covid-19 vaccine clinical trials are being conducted in SA, and two vaccines are potentially being manufactured right here. But there is no guarantee of preferential pricing or supplies for South Africans.
But take heart: if you belong to a medical aid scheme, you’ll receive the vaccine as a prescribed minimum benefit, according to Business Day.
This story was originally published in The Wrap here.
That’s a really inspiring story right? Subscribe here to receive news like this every Thursday on your phone or email.
Verashni Pillay
Verashni is passionate about empowering citizens to hold those in power to account. She was previously editor-in-chief of the Mail & Guardian and HuffPost South Africa, and won the CNN African Journalism Award, among others.
Sign up for our award-winning weekly Wrap of the news here. Check out our Weekly Roundup section for our Wrap archive.
Latest Stories
Does SA need a COVID-like ministerial advisory committee to deal with HIV funding cuts?
Q&A| How the incoming US tariff hikes will impact South Africa
Joburg’s green spaces at risk: COJ’s quiet move to sell public land alarms residents
ConCourt drama: Can Cyril bench his own player?